-
公开(公告)号:US20190359652A1
公开(公告)日:2019-11-28
申请号:US16478966
申请日:2018-01-19
Applicant: Tokyo University of Pharmacy & Life Sciences , National Cerebral and Cardiovascular Center , Kyoto Pharmaceutical University
Inventor: Yoshio HAYASHI , Kentaro TAKAYAMA , Mikiya MIYAZATO , Kenji KANGAWA , Kenji MORI , Akira YAMAMOTO , Toshiyasu SAKANE
Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
-
公开(公告)号:US20240277657A1
公开(公告)日:2024-08-22
申请号:US18566730
申请日:2022-06-03
Applicant: KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Susumu Nakata , Naoto Kojima
IPC: A61K31/381 , A61K31/415 , A61P35/00 , C07D231/14 , C07D333/38
CPC classification number: A61K31/381 , A61K31/415 , A61P35/00 , C07D231/14 , C07D333/38
Abstract: The present invention aims to provide a novel AMP-activated protein kinase activator.
The present invention relates to a compound represented by the formula (I):
wherein each symbol is as described in the specification, or a salt thereof, or a hydrate thereof. In addition, the present invention relates to an AMP-activated protein kinase activator containing the aforementioned compound, and a medicament containing the aforementioned compound for the prophylaxis and/or treatment of cancer.-
公开(公告)号:US20200237669A1
公开(公告)日:2020-07-30
申请号:US16628530
申请日:2018-07-06
Applicant: KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Hidemasa Katsumi , Akira Yamamoto
IPC: A61K9/14 , A61K31/401 , A61K47/60 , A61P13/12
Abstract: The present invention relates to a compound having a macromolecular carrier having a plurality of terminal groups, wherein the carbonyl group of serine is linked by a peptide bond or an ester bond directly or via a linker to the terminal groups, a carrier for drug delivery composed of the compound, and a medicament for preventing or treating renal diseases, containing the carrier for drug delivery and a drug bonded to the carrier directly or via a linker or encapsulated therein. According to the present invention, a carrier for drug delivery that is selectively accumulated in kidney in vivo can be provided.
-
公开(公告)号:US20210387197A1
公开(公告)日:2021-12-16
申请号:US17317273
申请日:2021-05-11
Applicant: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY , KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Katsuo MOGI , Tohru NATSUME , Shungo ADACHI , Tomoya INOUE , Hiroyuki KIMURA
IPC: B01L3/00
Abstract: A method for producing a liquid reaction mixture containing a radioisotope, in particular, a radioactive composition, minimizes device contamination with radioactive substances and increase speed and accuracy with which droplets are mixed. The method for producing a radioactive composition includes placing at least one first droplet L1 containing a radionuclide and at least one second droplet L2 containing a labeling substance on at least two respective dimples 5 among dimples 5 on a front surface 4b of an insulating layer 4 of a liquid manipulation device 1, and obtaining a liquid mixture M by using a change in electrostatic force caused by changing voltage applied to the electrodes 3 to thereby cause a relative movement between the at least one first droplet L1 and the at least one second droplet L2 so that the at least one first droplet L1 and the at least one second droplet L2 are mixed together at any one dimple among the dimples 5.
-
公开(公告)号:US20210299267A1
公开(公告)日:2021-09-30
申请号:US15999756
申请日:2017-02-17
Applicant: KYOTO UNIVERSITY , KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Asako YAMAYOSHI , Akira MURAKAMI , Eishi ASHIHARA , Akio KOBORI
Abstract: The present invention provides a conjugate comprising an antibody or antibody fragment targeting an exosome surface antigen, and an inhibitor of a gene or an expression product thereof, wherein the antibody or antibody fragment and the inhibitor of a gene or an expression product thereof are covalently bonded either directly or via a linker, or are non-covalently bonded.
-
公开(公告)号:US11548004B2
公开(公告)日:2023-01-10
申请号:US17317273
申请日:2021-05-11
Applicant: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY , KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Katsuo Mogi , Tohru Natsume , Shungo Adachi , Tomoya Inoue , Hiroyuki Kimura
IPC: B01L3/00
Abstract: A method for producing a liquid reaction mixture containing a radioisotope, in particular, a radioactive composition, minimizes device contamination with radioactive substances and increase speed and accuracy with which droplets are mixed. The method for producing a radioactive composition includes placing at least one first droplet L1 containing a radionuclide and at least one second droplet L2 containing a labeling substance on at least two respective dimples 5 among dimples 5 on a front surface 4b of an insulating layer 4 of a liquid manipulation device 1, and obtaining a liquid mixture M by using a change in electrostatic force caused by changing voltage applied to the electrodes 3 to thereby cause a relative movement between the at least one first droplet L1 and the at least one second droplet L2 so that the at least one first droplet L1 and the at least one second droplet L2 are mixed together at any one dimple among the dimples 5.
-
公开(公告)号:US20220362278A1
公开(公告)日:2022-11-17
申请号:US17624112
申请日:2020-07-01
Applicant: KYOTO PHARMACEUTICAL UNIVERSITY
Inventor: Hidemasa Katsumi , Akira Yamamoto
IPC: A61K31/7088 , A61K49/00 , A61K47/42 , A61K47/64 , A61P13/12
Abstract: The present invention aims to provide a carrier for drug delivery that selectively accumulates in the kidney in the body, and shows high biodegradability and drug releasability in the kidney. The present invention relates to a compound in which a carbonyl group of serine is linked directly or via a linker to terminal amino group of linear polylysine, compound carrier for delivery, and a medicament for the diagnosis, prophylaxis, or treatment of a renal disease, containing the carrier for drug delivery, and a drug bound to the carrier directly or via a linker or encapsulated therein.
-
公开(公告)号:US10550153B2
公开(公告)日:2020-02-04
申请号:US16478966
申请日:2018-01-19
Applicant: Tokyo University of Pharmacy & Life Sciences , National Cerebral and Cardiovascular Center , Kyoto Pharmaceutical University
Inventor: Yoshio Hayashi , Kentaro Takayama , Mikiya Miyazato , Kenji Kangawa , Kenji Mori , Akira Yamamoto , Toshiyasu Sakane
Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
-
-
-
-
-
-
-